The aim of this study was to evaluate the diagnostic and prognostic utility of the type 1 growth factor receptor family in the management of differentiated thyroid cancer (DTC).
Department of Surgery, St. Paul's Hospital, University of British Columbia, C303-1081 Burrard St., Vancouver, British Columbia, Canada V6Z-1Y6. smwiseman@providencehealth.bc.ca